Spyre Therapeutics, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 04/08/2026 | Mar 2026Filed 04/08/2026 | Sep 2025Filed 04/11/2025 | Jun 2025Filed 04/08/2026 | Mar 2025Filed 04/08/2026 | Sep 2024Filed 04/11/2025 | Jun 2024Filed 04/11/2025 | Mar 2024Filed 04/11/2025 |
|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | $0 | $0 | $0 | |
| −$36 | −$69 | −$11 | −$37 | −$45 | −$69 | −$39 | −$44 | |
| — | −$0.74 | — | — | — | $1.06 | $0.59 | $0.72 | |
| — | — | — | — | — | 51 | 45 | 37 |
Trend